Genetic Testing in Inherited Heart Diseases

Area of Science:

• Cardiology
• Genetics
• Clinical Medicine

Background:

• Inherited heart diseases encompass a spectrum of conditions, including hypertrophic cardiomyopathy (HCM), familial hypercholesterolaemia (FH), and inherited arrhythmia syndromes like long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), and Brugada syndrome (BrS).
• Genetic testing has become a cornerstone in the clinical management of these cardiovascular disorders.
• Cardiac manifestations can be indicative of broader genetic syndromes, where genetic testing aids in etiological clarification.

Purpose of the Study:

• To highlight the evolving role and utility of genetic testing in the diagnosis and management of inherited heart diseases.
• To emphasize the importance of genetic testing in identifying at-risk asymptomatic family members.
• To underscore the need for specialized multidisciplinary clinics and genetic counseling for cardiac genetic testing.

Main Methods:

• Review of current advancements in genetic testing technologies for cardiovascular diseases.
• Analysis of the clinical utility of genetic diagnoses in inherited heart conditions.
• Discussion of the integration of genetic testing into specialized cardiac clinics.

Main Results:

• Genetic testing is now a mainstream component in managing inherited heart diseases.
• Genetic diagnoses are particularly valuable for assessing risk in asymptomatic relatives.
• Clarification of underlying causes for cardiac manifestations within wider syndromes is facilitated by genetic testing.

Conclusions:

• Genetic testing plays a pivotal role in the diagnosis and risk stratification of inherited heart diseases.
• Specialized multidisciplinary cardiac clinics with genetic counseling are essential for optimal patient care.
• Early genetic diagnosis enables proactive management and familial screening for cardiovascular genetic disorders.